Grants and Contributions:
Title:
Creating international markets for on-site Legionella DNA testing
Agreement Number:
936000
Agreement Value:
$74,625.00
Agreement Date:
Oct 2, 2019 - Mar 15, 2020
Description:
Spartan has created the first on-site Legionella DNA test to prevent Legionnaires’ disease outbreaks. This project will enable Spartan to build on our initial success in North America and export the test to a key export markets.
Organization:
National Research Council Canada
Expected Results:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Ottawa, Ontario, CA k2h 1b2
Reference Number:
172-2019-2020-Q3-936000
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
855952438
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 74,625 dollars.
Amendment Date
Feb 14, 2020
Recipient's Legal Name:
Spartan Bioscience Inc
Federal Riding Name:
Ottawa West--Nepean
Federal Riding Number:
35079
Program:
CanExport SMEs
Program Purpose:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
334512
Amendments: